A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 63
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CK5
Long Form : cytokeratin 5
No. Year Title Co-occurring Abbreviation
2020 Cytokeratin 5 alters beta-catenin dynamics in breast cancer cells. CSC, ER
2020 Increased in vitro migration of human umbilical cord mesenchymal stem cells toward acellular foreskin treated with bacterial derivatives of monophosphoryl lipid A or supernatant of Lactobacillus acidophilus. HUMSCs, IHC, MMP-2, MPLA, qRT-PCR, SEM, SLA
2019 Fresh Cut Versus Stored Cut Paraffin-embedded Tissue: Effect on Immunohistochemical Staining for Common Breast Cancer Markers. EGFR, ER, HER2
2019 Hypopigmentation in burns is associated with alterations in the architecture of the skin and the dendricity of the melanocytes. FM, IHC, PBHS, TRP-1
2018 Diagnostic Utility of Cytokeratin-5 for the Identification of Proliferative Inflammatory Atrophy in the Canine Prostate. HE, PIA
2018 Identification of a Subtype of Poorly Differentiated Invasive Ductal Carcinoma of the Breast Based on Vimentin and E-cadherin Expression. ER and PgR, HER2, IDCs, IHC, TMA, VIM
2018 Postnatal changes in the development of rat submandibular glands in offspring of diabetic mothers: Biochemical, histological and ultrastructural study. AQP5, Bax, Bcl-2, EGF, PAS, PCNA, STZ
2018 The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten. CAH, EMC
2017 Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells. CSC, PR, PRE, RA, RAR, RARE, siRNA
10  2017 Double staining: diagnostic utility in non-small cell lung carcinoma in the era of tissue conservation. ADC, CB, FNA, IHC, NPV, NSCC, PPV, SqCC
11  2017 Expression of c-kit and Cytokeratin 5 in the Submandibular Gland after Release of Long-Term Ligation of the Main Excretory Duct in Mice. ---
12  2016 Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ. ADH, DCIS, ER, PR, UDH
13  2016 Interaction Between Beta-Catenin and EGFR Expression by Immunohistochemistry Identifies Prognostic Subgroups in Early High-risk Triple-negative Breast Cancer. EGFR, TNBC
14  2016 MALDI Mass Spectrometry Imaging Reveals Decreased CK5 Levels in Vulvar Squamous Cell Carcinomas Compared to the Precursor Lesion Differentiated Vulvar Intraepithelial Neoplasia. dVIN, IHC, MALDI-MSI, VSCC
15  2016 Noninvasive Papillary Basal-like Urothelial Carcinoma: A Subgroup of Urothelial Carcinomas With Immunohistochemical Features of Basal Urothelial Cells Associated With a High Rate of Recurrence and Progression. BUC, UCs
16  2016 Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism. ERalpha
17  2016 Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma. nap-A, TTF-1
18  2016 [Basal-luminal epithelial cell differentiation in prostate cancer is associated with epithelial-mesenchymal transition and epithelium migration in the mesenchyme]. ---
19  2015 Cytokeratin 5-Positive Cells Represent a Therapy Resistant subpopulation in Epithelial Ovarian Cancer. ER
20  2015 Evaluation of p40 as a Myoepithelial Marker in Different Breast Lesions. MEC
21  2015 Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes. BCSS, EGFR, HER2, IDC, ILC, PR
22  2015 Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features. BUC, UC
23  2015 Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. ER, MaSC, miR, PR, STAT5a
24  2015 Subcutaneous transplantation promotes organ formation of the fetal rat urogenital sinus. AR, BPH, CK8, UGS
25  2014 Application of combined immunohistochemical panel of AMACR(P504S)/p63 cocktail, cytokeratin 5 and D2-40 to atypical glands in prostatic needle biopsy. ---
26  2014 Deletion of atbf1/zfhx3 in mouse prostate causes neoplastic lesions, likely by attenuation of membrane and secretory proteins and multiple signaling pathways. mPIN
27  2014 Localized amyloidosis of the vulva with and without vulvar intraepithelial neoplasia: report of a series. CK14
28  2014 Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease. EGFR, ER, pLB, pLUM, PR
29  2014 Nested and microcystic variants of urothelial carcinoma displaying immunohistochemical features of basal-like urothelial cells: an immunohistochemical and histopathogenetic study. IP, UC
30  2014 p40 (DeltaNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis. ADC, CB, FNA, IHC, SqCC
31  2014 Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression. Pg
32  2013 Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup. comedo-DCIS, EGFR, ER, PgR
33  2013 Immunohistochemistry in the differential diagnostics of primary lung cancer: an investigation within the Southern Swedish Lung Cancer Study. IHC, TTF-1
34  2013 Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties. ER, PR
35  2013 Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. ER, KLF4, PR
36  2012 A high-content assay to identify small-molecule modulators of a cancer stem cell population in luminal breast cancer. ER, GFP, PR
37  2012 Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel. BCP, DFS, ER, FFPE, IHC, OS, PgR
38  2012 Morphological aspects and immunophenotypic profiles of mammary carcinomas in benign-mixed tumors of female dogs. CBMT, ER, HER2, PR
39  2011 Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study. EGFR, ER, PgR, TMA
40  2011 Clinicopathlogic and immunohistochemical characteristics of triple negative invasive lobular carcinoma. IHC, ILC, TNC
41  2011 Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers. ER, TICs
42  2011 Increased urothelial cell detection in the primary bladder smooth muscle cell cultures with dual MACS/qRT-PCR approach. qRT-PCR, SMC
43  2011 Long-term cultures of stem/progenitor cells from lobular and ductal breast carcinomas under non-adherent conditions. alpha-SMA
44  2011 Prospective isolation and characterization of committed and multipotent progenitors from immortalized mouse mammary epithelial cells with morphogenic potential. CDbeta, NSP, SP
45  2011 Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer. ABCG2, AR, CRPC, DHT, PCa
46  2011 The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. KLF5, Pg, PR
47  2010 Stem cell characteristics in prostate cancer cell lines. BCRP, CK18, FACS, PCa
48  2010 [Proportion of intermediate epithelial cells and human prostate cancer]. AIPC, AR, CK8
49  2009 Abnormal differentiation, hyperplasia and embryonic/perinatal lethality in BK5-T/t transgenic mice. BK5, SV40
50  2009 Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy. ER
51  2009 From conventional pathologic diagnosis to the molecular classification of breast carcinoma: are we ready for the change? EGFR, ER, PR
52  2009 Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. HGPIN, PCa, PIA
53  2008 High levels of expression of cytokeratin 5 are strongly correlated with poor survival in higher grades of mucoepidermoid carcinoma. MEC
54  2008 The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis. ---
55  2007 Adenosquamous carcinoma with cilium formation, mucin production and keratinization in the nasal cavity of a red fox (Vulpes vulpes schrencki). ---
56  2007 P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ. DCIS, EGFR, ER, P-CD
57  2006 Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury. ---
58  2006 Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas. ---
59  2006 [Expression of cytokeratin 5 and calretinin in clear-cell renal cell carcinoma]. ---
60  2005 Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer. ---
61  2002 Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. dn
62  2002 Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. SMA
63  2002 Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. ---